Literature DB >> 19885692

Psychophysical assessment of low visual function in patients with retinal degenerative diseases (RDDs) with the Diagnosys full-field stimulus threshold (D-FST).

M Klein1, D G Birch.   

Abstract

To determine whether the Diagnosys full-field stimulus threshold (D-FST) is a valid, sensitive and repeatable psychophysical method of measuring and following visual function in low-vision subjects. Fifty-three affected eyes of 42 subjects with severe retinal degenerative diseases (RDDs) were tested with achromatic stimuli on the D-FST. Included were subjects who were either unable to perform a static perimetric field or had non-detectable or sub-microvolt electroretinograms (ERGs). A subset of 21 eyes of 17 subjects was tested on both the D-FST and the FST2, a previous established full-field threshold test. Seven eyes of 7 normal control subjects were tested on both the D-FST and the FST2. Results for the two methods were compared with the Bland-Altman test. On the D-FST, a threshold could successfully be determined for 13 of 14 eyes with light perception (LP) only (median 0.9 +/- 1.4 log cd/m2), and all eyes determined to be counting fingers (CF; median 0.3 +/- 1.8 log cd/m2). The median full-field threshold for the normal controls was -4.3 +/- 0.6 log cd/m2 on the D-FST and -4.8 +/- 0.9 log cd/m2 on the FST2. The D-FST offers a commercially available method with a robust psychophysical algorithm and is a useful tool for following visual function in low vision subjects.

Entities:  

Mesh:

Year:  2009        PMID: 19885692      PMCID: PMC5319829          DOI: 10.1007/s10633-009-9204-7

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  14 in total

1.  Comparison of the Goldmann-Weekers dark adaptometer and LKC Technologies Scotopic Sensitivity tester-1.

Authors:  A Y Peters; K G Locke; D G Birch
Journal:  Doc Ophthalmol       Date:  2000-07       Impact factor: 2.379

2.  Gene therapy restores vision in a canine model of childhood blindness.

Authors:  G M Acland; G D Aguirre; J Ray; Q Zhang; T S Aleman; A V Cideciyan; S E Pearce-Kelling; V Anand; Y Zeng; A M Maguire; S G Jacobson; W W Hauswirth; J Bennett
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

3.  Feasibility study of a retinal prosthesis: spatial vision with a 16-electrode implant.

Authors:  Avi Caspi; Jessy D Dorn; Kelly H McClure; Mark S Humayun; Robert J Greenberg; Matthew J McMahon
Journal:  Arch Ophthalmol       Date:  2009-04

4.  Extracting thresholds from noisy psychophysical data.

Authors:  W H Swanson; E E Birch
Journal:  Percept Psychophys       Date:  1992-05

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures.

Authors:  Alejandro J Roman; Sharon B Schwartz; Tomas S Aleman; Artur V Cideciyan; John D Chico; Elizabeth A M Windsor; Leigh M Gardner; Gui-Shuang Ying; Elaine E Smilko; Maureen G Maguire; Samuel G Jacobson
Journal:  Exp Eye Res       Date:  2005-02       Impact factor: 3.467

7.  Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration.

Authors:  Yuji Inoue; Aya Iriyama; Shuji Ueno; Hidenori Takahashi; Mineo Kondo; Yasuhiro Tamaki; Makoto Araie; Yasuo Yanagi
Journal:  Exp Eye Res       Date:  2007-05-06       Impact factor: 3.467

8.  Effect of gene therapy on visual function in Leber's congenital amaurosis.

Authors:  James W B Bainbridge; Alexander J Smith; Susie S Barker; Scott Robbie; Robert Henderson; Kamaljit Balaggan; Ananth Viswanathan; Graham E Holder; Andrew Stockman; Nick Tyler; Simon Petersen-Jones; Shomi S Bhattacharya; Adrian J Thrasher; Fred W Fitzke; Barrie J Carter; Gary S Rubin; Anthony T Moore; Robin R Ali
Journal:  N Engl J Med       Date:  2008-04-27       Impact factor: 91.245

9.  Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations.

Authors:  Samuel G Jacobson; Tomas S Aleman; Artur V Cideciyan; Alejandro J Roman; Alexander Sumaroka; Elizabeth A M Windsor; Sharon B Schwartz; Elise Heon; Edwin M Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-30       Impact factor: 4.799

10.  Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.

Authors:  William W Hauswirth; Tomas S Aleman; Shalesh Kaushal; Artur V Cideciyan; Sharon B Schwartz; Lili Wang; Thomas J Conlon; Sanford L Boye; Terence R Flotte; Barry J Byrne; Samuel G Jacobson
Journal:  Hum Gene Ther       Date:  2008-10       Impact factor: 5.695

View more
  27 in total

1.  Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.

Authors:  Stephen Russell; Jean Bennett; Jennifer A Wellman; Daniel C Chung; Zi-Fan Yu; Amy Tillman; Janet Wittes; Julie Pappas; Okan Elci; Sarah McCague; Dominique Cross; Kathleen A Marshall; Jean Walshire; Taylor L Kehoe; Hannah Reichert; Maria Davis; Leslie Raffini; Lindsey A George; F Parker Hudson; Laura Dingfield; Xiaosong Zhu; Julia A Haller; Elliott H Sohn; Vinit B Mahajan; Wanda Pfeifer; Michelle Weckmann; Chris Johnson; Dina Gewaily; Arlene Drack; Edwin Stone; Katie Wachtel; Francesca Simonelli; Bart P Leroy; J Fraser Wright; Katherine A High; Albert M Maguire
Journal:  Lancet       Date:  2017-07-14       Impact factor: 79.321

2.  Chapter 8 - Restoring Vision to the Blind: Evaluating Visual Function, Endpoints.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

3.  Interim results from the international trial of Second Sight's visual prosthesis.

Authors:  Mark S Humayun; Jessy D Dorn; Lyndon da Cruz; Gislin Dagnelie; José-Alain Sahel; Paulo E Stanga; Artur V Cideciyan; Jacque L Duncan; Dean Eliott; Eugene Filley; Allen C Ho; Arturo Santos; Avinoam B Safran; Aries Arditi; Lucian V Del Priore; Robert J Greenberg
Journal:  Ophthalmology       Date:  2012-01-11       Impact factor: 12.079

4.  Toward a clinical protocol for assessing rod, cone, and melanopsin contributions to the human pupil response.

Authors:  Jason C Park; Ana L Moura; Ali S Raza; David W Rhee; Randy H Kardon; Donald C Hood
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-22       Impact factor: 4.799

5.  Presentation of TRPM1-Associated Congenital Stationary Night Blindness in Children.

Authors:  Virginia Miraldi Utz; Wanda Pfeifer; Susannah Q Longmuir; Richard John Olson; Kai Wang; Arlene V Drack
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

6.  The Detection of Motion by Blind Subjects With the Epiretinal 60-Electrode (Argus II) Retinal Prosthesis.

Authors:  Jessy D Dorn; Ashish K Ahuja; Avi Caspi; Lyndon da Cruz; Gislin Dagnelie; Jose-Alain Sahel; Robert J Greenberg; Matthew J McMahon
Journal:  JAMA Ophthalmol       Date:  2013-02       Impact factor: 7.389

7.  A pilot study of an acupuncture protocol to improve visual function in retinitis pigmentosa patients.

Authors:  Ava K Bittner; Jeffrey M Gould; Andy Rosenfarb; Collin Rozanski; Gislin Dagnelie
Journal:  Clin Exp Optom       Date:  2013-10-29       Impact factor: 2.742

8.  Harmonization of Outcomes and Vision Endpoints in Vision Restoration Trials: Recommendations from the International HOVER Taskforce.

Authors:  Lauren N Ayton; Joseph F Rizzo; Ian L Bailey; August Colenbrander; Gislin Dagnelie; Duane R Geruschat; Philip C Hessburg; Chris D McCarthy; Matthew A Petoe; Gary S Rubin; Philip R Troyk
Journal:  Transl Vis Sci Technol       Date:  2020-07-16       Impact factor: 3.283

9.  Psychophysically determined full-field stimulus thresholds (FST) in retinitis pigmentosa: relationships with electroretinography and visual field outcomes.

Authors:  Katharina Messias; Herbert Jägle; Rafael Saran; André Domingos Pinto Ruppert; Rubens Siqueira; Rodrigo Jorge; André Messias
Journal:  Doc Ophthalmol       Date:  2013-06-04       Impact factor: 2.379

10.  Full-Field Pupillary Light Responses, Luminance Thresholds, and Light Discomfort Thresholds in CEP290 Leber Congenital Amaurosis Patients.

Authors:  Frederick T Collison; Jason C Park; Gerald A Fishman; J Jason McAnany; Edwin M Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-11       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.